Navigation Links
'Prosthetic' retinal cells let blind mice see light

In an experiment that could offer a new pathway to restoring vision in people with inherited retinal degeneration, researchers have engineered cells in the eye to be light sensitive that were not before. Using a harmless virus, they introduced a gene for a light-sensitive protein into "inner retinal neurons" in a strain of mice with photoreceptor deficiency that resembles the defect in such inherited human disorders as retinitis pigmentosa. Unlike the retinal rods and cones that normally function as light-sensing cells in the eye, these retinal neurons are normally not photosensitive. The light-sensitive protein they used, called channelrhodopsin-2 (ChR2), is found in green algae.

As reported in the April 6, 2006 issue of Neuron, Zhuo-Hua Pan of Wayne State University School of Medicine and colleagues found that the introduced protein rendered the retinal neurons sensitive to light. What's more, they found, the protein persisted for long periods in the neurons, and the neurons generated signals that were transmitted to the visual cortex of the animals' brains.

"With this strategy, the investigators have made a paradigm shift in the field and opened the possibility of genetically modifying the surviving retinal interneurons to function as a replacement light-sensing receptor," wrote John Flannery and Kenneth Greenberg in a preview of the paper in the same issue of Neuron. "This publication is clearly a significant first step into this new field of re-engineering retinal interneurons as genetically modified 'prosthetic' cells," they wrote.

Pan and his colleagues cautioned that far more research must be done to determine whether their genetic engineering approach can be applied to restore vision in humans with inherited retinal degeneration disorders. For one thing, they said, they have not yet determined whether the light signals reaching the visual cortex could be interpreted as vision. Also, the algal protein is less sensitive to light than is the normal light-detecting protein in the eye.

Finally, they wrote, it remains unclear which of the many inherited retinal diseases might be treatable by using the technique. "The remodeling of inner retinal neurons triggered by photoreceptor degeneration has raised some concerns for the retinal-based rescue strategy after the death of photoreceptors," wrote Pan and colleagues. "However, retinal degenerative diseases are heterogeneous as to the time course of the degeneration, survival cell types, and, possibly, their functional state. Therefore, further studies are required to evaluate what types of retinal degenerative diseases and/or what disease stages are suitable for this potential treatment strategy," they wrote.

However, noted the researchers, their technique avoids some problems presented by other approaches to restoring vision in such diseases. These approaches include transplantation of normal photoreceptor cells into the eye or implantation of electronic retinal "chips" to replace the photoreceptor function.

"An important advantage of the strategy sought in this study is that it does not involve the introduction of tissues or devices into the retina and, therefore, may largely avoid the complications of immune reactions and biocompability," wrote the researchers. "In addition, it could potentially achieve high spatial resolution for the restored 'vision' because the approach targets the cellular level. Thus, the expression of microbial-type channelrhodopsins, such as ChR2, in surviving retinal neurons may be another potential strategy for the treatment of complete blindness caused by rod and cone degeneration," they wrote.


'"/>

Source:Cell Press


Related biology news :

1. Six previously blind patients detect light, motion, identify objects with retinal prostheses
2. New gene reduces retinal degeneration in fruit flies
3. Transplanted photoreceptor precursor cells restore visual function in mice with retinal degeneration
4. Wisconsin scientists grow critical nerve cells
5. Spleen may be source of versatile stem cells
6. Researchers discover way to make cells in the eye sensitive to light
7. Priming embryonic stem cells to fulfill their promise
8. Lack of enzyme turns fat cells into fat burners
9. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
10. Elusive HIV shape change revealed; Key clue to how virus infects cells
11. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
(Date:1/22/2016)... 22, 2016 ... the "Global Biometrics Market in Retail ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ... Biometrics Market in Retail Sector 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ...
(Date:1/20/2016)... A market that just keeps on growing. Molecular Diagnostics ... genomics knowledge. Learn all about it in this new ... trends are pushing market growth and company valuations. Trends ... pathogen evolution - next generation sequencing - emergence of ... the role of genetic material in Disease and Health ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... RICHMOND, Calif. , Feb. 4, 2016  Sangamo ... therapeutic genome editing, announced today that Edward Lanphier ... an update on the progress of Sangamo,s ZFP Therapeutic ... company,s business strategy at 2:40 pm ET on Thursday, ... Annual Global Healthcare Conference. The conference is being ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Forensics Club, takes place February 5-6 at the University’s student center, Kehr ... activities such as workshops and competitions for ample networking, learning and collaborating ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... , February 4, 2016 --> ... biotechnology acceleration company is pleased to provide the following update ... --> Over the last 3 months we have significantly ... purchase agreements exceeding $1,000,000. As a result, we have positioned ... Research Inc. license agreement and expect that development to continue ...
Breaking Biology Technology: